Chatzipavlidou V - Search Results

1

Associating radioiodine therapy in hyperthyroidism with cancer mortality: robust or random results of a statistical analysis?

Iakovou I, Giannoula E, Chatzipavlidou V, Sachpekidis C. Iakovou I, et al. Among authors: chatzipavlidou v. Hell J Nucl Med. 2020 Jan-Apr;23(1):94-95. doi: 10.1967/s002449912018. Hell J Nucl Med. 2020. PMID: 32361719 Free article.

2

[The role of positron emission tomography in in lymphoma diagnosis and treatment].

Papamichael DC, Pianou NK, Chatzipavlidou V. Papamichael DC, et al. Among authors: chatzipavlidou v. Hell J Nucl Med. 2015 May-Aug;18(2):173-9. doi: 10.1967/s002449910216. Epub 2015 Jul 20. Hell J Nucl Med. 2015. PMID: 26187221 Greek, Modern.

3

[Risk factors and the progression of thyroid malignancies].

Giannoula E, Iakovou I, Chatzipavlidou V. Giannoula E, et al. Among authors: chatzipavlidou v. Hell J Nucl Med. 2015 Sep-Dec;18(3):275-84. doi: 10.1967/s002449910307. Epub 2015 Nov 18. Hell J Nucl Med. 2015. PMID: 26574695 Review. Greek, Modern.

4

[Neuroendocrine tumors: Peptide receptors radionuclide therapy (PRRT)].

Papamichail DG, Exadaktylou PE, Chatzipavlidou VD. Papamichail DG, et al. Hell J Nucl Med. 2016 Jan-Apr;19(1):75-82. Hell J Nucl Med. 2016. PMID: 27035909 Review. Greek, Modern.

5

Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.

Panagiotidis E, Paschali A, Giannoula E, Chatzipavlidou V. Panagiotidis E, et al. Among authors: chatzipavlidou v. Clin Nucl Med. 2019 Jan;44(1):e46-e48. doi: 10.1097/RLU.0000000000002354. Clin Nucl Med. 2019. PMID: 30371591

6

A Mobile App for Thyroid Cancer Patients Aiming to Enhance Their Quality of Life: Protocol for a Quasiexperimental Interventional Pilot Study.

Giannoula E, Iakovou I, Katsikavelas I, Antoniou P, Raftopoulos V, Chatzipavlidou V, Papadopoulos N, Bamidis P. Giannoula E, et al. Among authors: chatzipavlidou v. JMIR Res Protoc. 2020 Mar 13;9(3):e13409. doi: 10.2196/13409. JMIR Res Protoc. 2020. PMID: 32167482 Free PMC article.

7

A new era for nuclear medicine.

Chatzipavlidou V. Chatzipavlidou V. Hell J Nucl Med. 2020 Jan-Apr;23(1):2-3. doi: 10.1967/s002449912013. Hell J Nucl Med. 2020. PMID: 32361714 Free article.

8

The modifications brought about by the COVID-19 pandemic to Nuclear Medicine practice.

Chatzipavlidou V. Chatzipavlidou V. Hell J Nucl Med. 2020 May-Aug;23 Suppl:6-7. Hell J Nucl Med. 2020. PMID: 32860389 Free article.

9

Nuclear thyroidology in pandemic times: The paradigm shift of COVID-19.

Giannoula E, Vrachimis A, Giovanella L, Chatzipavlidou V, Iakovou I. Giannoula E, et al. Among authors: chatzipavlidou v. Hell J Nucl Med. 2020 May-Aug;23 Suppl:41-50. Hell J Nucl Med. 2020. PMID: 32860396 Free article. Review.

10

A 4.000 € way to improve perceived quality and meet expectations of thyroid cancer patients receiving therapeutic dose of Iodine-131.

Giannoula E, Melidis C, Papadopoulos N, Bamidis P, Raftopoulos V, Chatzipavlidou V, Iakovou I. Giannoula E, et al. Among authors: chatzipavlidou v. Nucl Med Rev Cent East Eur. 2022;25(2):138-140. doi: 10.5603/NMR.a2022.0031. Nucl Med Rev Cent East Eur. 2022. PMID: 36047293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters